AlphaYouCR
Insider buying
Christoph Rudiger Antz bought $8K of Veraxa Biotech AG (VRXA) stock
Christoph Rudiger Antz, Chief Executive Officer of Veraxa Biotech AG (VRXA), bought 5,000 shares of VRXA stock worth $8K, per an SEC Form 4 filed Aug 31, 2026.
It was an open-market purchase.
The trade happened on Aug 27, 2026, 4 days before it was made public.
VRXA has moved -2.1% since the trade date, from $1.44 to $1.41 (Sep 22, 2026 close).
- Traded
- Aug 27, 2026
- Disclosed
- Aug 31, 2026
- Filing delay
- 4 days
- Price since
- -2.1%
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More VRXA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.